Data Integration and Analysis Core
- Institution
- CINCINNATI CHILDRENS HOSP MED CTR, OH
- Principal investigator
- Lisa J Martin
- Funding
- $127K
- Duration
- 2006–2026
Moonbase score
Still being scored
Abstract
Allergic diseases (asthma, allergic dermatitis (AD), allergic rhinitis, food allergy and eosinophilic esophagitis (EoE)) commonly affect US children and have substantial lifetime co-morbidity. Our findings over the last 3 funding cycles identify and implicate novel epithelial pathways as key drivers of allergic inflammation and allergic disease pathogenesis. However, how these key drivers and other epithelial pathways contribute to development, persistence, progression and remission of allergic disease remains largely unknown. Our Center is focused on refining current atopic march paradigms and elucidating the epithelial-centric mechanisms that drive the atopic march. This proposal’s overarching hypothesis is that homeostatic mechanisms at epithelial surfaces, upon dysregulation, promote allergic inflammation and contribute to the persistence, progression, remission, and resolution of allergic disease(s). This hypothesis will be tested by three integrated and synergistic projects that combine epidemiologic, basic, translational, and clinical research approaches. The Data Integration and Analysis Core’s (DIAC) purpose is to provide the quantitative expertise to accomplish the overall objectives, curate and integrate data, and perform synergistic analyses. The DIAC’s expertise in quantitative genetics, genomics, statistics, ancestry, and bioinformatics enhances the capacity for rigorous and reproducible research that will be applied to advance the goals of the overall Center as well as assist the project investigators with their specific hypotheses and aims. This DIAC’s aims are to 1) curate, integrate, and share data and results across the U19 Center team and with the scientific community; 2) provide analytic rigor and expertise to the Center Projects so that the Center can achieve its overarching goal and the Projects can achieve their goals; and 3) perform synergistic analyses across all Projects so the Center can achieve its full potential. Our longstanding success in evaluating the role of the epithelium in allergic disorders coupled with our MPAACH longitudinal cohort, novel experimental systems to perform mechanistic studies, and analytic expertise, uniquely position us to accomplish the Center objectives. Successful completion of the proposed studies will provide novel insights into a key question in the allergy field: Why is allergic inflammation restricted to one tissue in some cases, while it progresses to involve additional tissues in other individuals?
LOADING MOONBASE SCORE
Questions for CINCINNATI CHILDRENS HOSP MED CTR
Answered by the team behind this research.
No questions yet. Sign in to ask the first one
Related grants
Same institution, same topic, scored first.
- NIH · Cincinnati Childrens Hosp Med Ctr54
Sirolimus TSC Epilepsy Prevention Study (STEPS) IND#145820 11/8/2019
Martina Bebin · $651K · 2021–2027
- NIH · Cincinnati Childrens Hosp Med Ctr48
Abatacept for the treatment of Common Variable Immunodeficiency with Interstitial Lung Disease (ABCVILD) IND #152820 9/2/20
Michael Jordan · $530K · 2021–2027
- NIH · Cincinnati Childrens Hosp Med Ctr44
Molecular signaling in uterine receptivity to implantation
Xiaofei Sun · $439K · 2011–2028